BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 27034082)

  • 1. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
    de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
    Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic hypomagnesemia induced by proton-pump inhibitors (PPIs). A known adverse event that is worth recalling.
    Keco Huerga A; García de la Borbolla Serres J; Castro Fernández M
    Rev Esp Enferm Dig; 2021 Oct; 113(10):728-729. PubMed ID: 33720741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse effects of long-term proton-pump inhibitor therapy on adults].
    Igaz I; Simonyi G; Balogh S; Szathmári M
    Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors: potential adverse effects.
    Abraham NS
    Curr Opin Gastroenterol; 2012 Nov; 28(6):615-20. PubMed ID: 23010681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perils and pitfalls of long-term effects of proton pump inhibitors.
    Wilhelm SM; Rjater RG; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
    Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
    Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
    Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What is the REAL long-term risk of proton pump inhibitors?].
    Ribiere S; Guillaumot MA; Barré A; Abou Ali E; Barret M; Chaussade S; Coriat R
    Presse Med; 2019 May; 48(5):503-510. PubMed ID: 30926204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor therapy and potential long-term harm.
    Corleto VD; Festa S; Di Giulio E; Annibale B
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):3-8. PubMed ID: 24310148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
    Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
    Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the precautions with proton pump inhibitor use for reflux disease?
    Mospan CM
    JAAPA; 2015 Dec; 28(12):23-6. PubMed ID: 26595692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
    Scarpignato C; Gatta L; Zullo A; Blandizzi C; ;
    BMC Med; 2016 Nov; 14(1):179. PubMed ID: 27825371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of proton pump inhibitors.
    Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):193-201. PubMed ID: 20227032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proton pump inhibitors: not as safe as they seem].
    van Herwaarden N; Bos JM; Veldman B; Kramers C
    Ned Tijdschr Geneeskd; 2016; 160():D487. PubMed ID: 27438396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
    Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
    Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Emergent adverse effects of proton pump inhibitors].
    Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
    Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for the use of proton-pump inhibitors in older adults.
    Desilets AR; Asal NJ; Dunican KC
    Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.